We scan new podcasts and send you the top 5 insights daily.
While the FDA is adopting AI, it does not accept AI-generated outputs without human validation. Nader Fahy cites an FDA rejection of a company's submission that relied solely on an AI's assessment. This precedent underscores that for regulatory compliance, a "human in the loop" remains a non-negotiable requirement.
Beyond model capabilities and process integration, a key challenge in deploying AI is the "verification bottleneck." This new layer of work requires humans to review edge cases and ensure final accuracy, creating a need for entirely new quality assurance processes that didn't exist before.
To manage compliance risk in regulated industries, treat AI agents like new employees. Before deployment, the agent must pass the same knowledge assessment a human would take. This quantifies the risk, turning a 'black box' AI into an observable and testable system with a verifiable accuracy score.
For industries like insurance, deploying AI agents isn't just about functionality; it's about compliance. These companies require agents that produce deterministic, auditable outcomes to comply with regulations. This necessitates robust human-in-the-loop systems to prevent bias and ensure policy adherence, a major hurdle for production deployment.
Generative AI is designed for creative generation, not consistent output. This core feature makes it unreliable for critical, live applications without human oversight. Humans require predictable patterns, which current AI alone cannot guarantee, making a human at the helm essential for safety and trust.
To maintain trust, AI in medical communications must be subordinate to human judgment. The ultimate guardrail is remembering that healthcare decisions are made by people, for people. AI should assist, not replace, the human communicator to prevent algorithmic control over healthcare choices.
In an enterprise setting, "autonomous" AI does not imply unsupervised execution. Its true value lies in compressing weeks of human work into hours. However, a human expert must remain in the loop to provide final approval, review, or rejection, ensuring control and accountability.
Don't blindly trust AI. The correct mental model is to view it as a super-smart intern fresh out of school. It has vast knowledge but no real-world experience, so its work requires constant verification, code reviews, and a human-in-the-loop process to catch errors.
The concept of "human-in-the-loop" is often misapplied. To effectively manage autonomous AI agents, companies must map the agent's entire workflow and insert mandatory human approval at critical decision points, not just as a final check or initial hand-off.
A pharmaceutical manufacturer received an FDA warning letter not for using AI, but for failing to provide adequate human oversight. This signals that regulators are focused on the implementation and governance of AI systems, establishing a key compliance risk for the industry.
Stating a "human is in the loop" is often symbolic. For oversight to be effective, the manager must have the time, competence, and organizational permission to genuinely challenge and override an AI's recommendation, rather than just serving as a liability shield for a pre-framed decision.